Mixed results with metformin for men on ADT for prostate cancer

(MedPage Today) – Metformin failed to prevent metabolic syndrome in men receiving hormone therapy for prostate cancer, but it did improve risk factors associated with the syndrome, a brief randomized trial showed. The percentage of infected people…